Bliss GVS Pharma Ltd.

Bliss GVS Pharma Ltd. share price is ₹140.60 as of November 30, 2023, 10:14 AM. Share prices change over the course of a trading day, and may differ basis on exchange (NSE/BSE).

Market cap is calculated by multiplying the company's share price with the total outstanding shares. The market cap of Bliss GVS Pharma Ltd. is ₹1,479 Cr as of November 30, 2023.

The PE ratio of Bliss GVS Pharma Ltd. is 16.70 as of November 30, 2023.The PE ratio measures the current share price relative to the earnings of the company for past 12 months (as of last reported period).

The trailing twelve month (TTM) PB ratio of Bliss GVS Pharma Ltd. is 1.60 as of November 30, 2023. The PB ratio measures the market capitalization of the company relative to it’s book value (carrying value on the balance sheet) as of last reported period.

Upper Circuit is ₹155.35. Lower Circuit is ₹127.15.

Bliss GVS Pharma Ltd. reported an ROE of 8.01% for the last reported financial year on a consolidated account basis. Return on Equity (ROE) reflects how efficiently the company is able to generate profit as a percent of their equity financing.

Shareholding pattern gives insights on the concentration of holdings towards various groups of investors. As of last reported quarter for Bliss GVS Pharma Ltd., Promoter held 35.1%, the FII held 16.3%, DII held 6.6% and the public held 42% of the total shares.

You can easily buy shares of Bliss GVS Pharma Ltd. online through Share.Market. If you are an existing user, login to your account, else follow the process to create your own Demat and Trading account in a few easy steps.

Fair value in investing refers to the estimated potential price of the business. The market (or exchange) is expected to determine the fair value of listed companies by the way of demand and supply. To determine the fair value of Bliss GVS Pharma Ltd. as per market, look at the current bid and ask prices during the trading hours.